346 related articles for article (PubMed ID: 30279415)
21. Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.
Knies N; Alankus B; Weilemann A; Tzankov A; Brunner K; Ruff T; Kremer M; Keller UB; Lenz G; Ruland J
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7230-8. PubMed ID: 26668357
[TBL] [Abstract][Full Text] [Related]
22. The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation.
Palkowitsch L; Marienfeld U; Brunner C; Eitelhuber A; Krappmann D; Marienfeld RB
J Biol Chem; 2011 Mar; 286(9):7522-34. PubMed ID: 21199863
[TBL] [Abstract][Full Text] [Related]
23. COP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulation.
Welteke V; Eitelhuber A; Düwel M; Schweitzer K; Naumann M; Krappmann D
EMBO Rep; 2009 Jun; 10(6):642-8. PubMed ID: 19444310
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase C-δ negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosome.
Liu Y; Song R; Gao Y; Li Y; Wang S; Liu HY; Wang Y; Hu YH; Shu HB
J Biol Chem; 2012 Jun; 287(24):20081-7. PubMed ID: 22528498
[TBL] [Abstract][Full Text] [Related]
25. Germline CBM-opathies: From immunodeficiency to atopy.
Lu HY; Biggs CM; Blanchard-Rohner G; Fung SY; Sharma M; Turvey SE
J Allergy Clin Immunol; 2019 May; 143(5):1661-1673. PubMed ID: 31060714
[TBL] [Abstract][Full Text] [Related]
26. Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells.
Rosenbaum M; Gewies A; Pechloff K; Heuser C; Engleitner T; Gehring T; Hartjes L; Krebs S; Krappmann D; Kriegsmann M; Weichert W; Rad R; Kurts C; Ruland J
Nat Commun; 2019 May; 10(1):2352. PubMed ID: 31138793
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.
Lork M; Staal J; Beyaert R
Cell Immunol; 2019 Jun; 340():103877. PubMed ID: 30514565
[TBL] [Abstract][Full Text] [Related]
28. The CBM complex: A growing multiplicity of cellular functions, regulatory mechanisms and connections to human disease.
Schaefer BC
Cell Immunol; 2020 Oct; 356():104189. PubMed ID: 32771677
[No Abstract] [Full Text] [Related]
29. Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases.
Zhang YY; Peng J; Luo XJ
Biochem Pharmacol; 2022 Apr; 198():114977. PubMed ID: 35218741
[TBL] [Abstract][Full Text] [Related]
30. Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation.
Oeckinghaus A; Wegener E; Welteke V; Ferch U; Arslan SC; Ruland J; Scheidereit C; Krappmann D
EMBO J; 2007 Nov; 26(22):4634-45. PubMed ID: 17948050
[TBL] [Abstract][Full Text] [Related]
31. The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.
Turvey SE; Durandy A; Fischer A; Fung SY; Geha RS; Gewies A; Giese T; Greil J; Keller B; McKinnon ML; Neven B; Rozmus J; Ruland J; Snow AL; Stepensky P; Warnatz K
J Allergy Clin Immunol; 2014 Aug; 134(2):276-84. PubMed ID: 25087226
[TBL] [Abstract][Full Text] [Related]
32. Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
Howes A; O'Sullivan PA; Breyer F; Ghose A; Cao L; Krappmann D; Bowcock AM; Ley SC
Biochem J; 2016 Jun; 473(12):1759-68. PubMed ID: 27071417
[TBL] [Abstract][Full Text] [Related]
33. The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damage-induced NF-κB activation and cell survival.
Zhang S; Pan D; Jia XM; Lin X; Zhao X
Protein Cell; 2017 Nov; 8(11):856-860. PubMed ID: 28717989
[No Abstract] [Full Text] [Related]
34. Methods to Study CARD11-BCL10-MALT1 Dependent Canonical NF-κB Activation in Jurkat T Cells.
Gewies A; Graß C; Krappmann D
Methods Mol Biol; 2021; 2366():125-143. PubMed ID: 34236636
[TBL] [Abstract][Full Text] [Related]
35. Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons.
Wang W; Chang X; Yao W; Wei N; Huo N; Wang Y; Wei Q; Liu H; Wang X; Zhang S; Yang Z; Xiao S
J Virol; 2019 Dec; 93(24):. PubMed ID: 31554683
[TBL] [Abstract][Full Text] [Related]
36. Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency.
Lu HY; Sharma M; Sharma AA; Lacson A; Szpurko A; Luider J; Dharmani-Khan P; Shameli A; Bell PA; Guilcher GMT; Lewis VA; Vasquez MR; Desai S; McGonigle L; Murguia-Favela L; Wright NAM; Sergi C; Wine E; Overall CM; Suresh S; Turvey SE
J Allergy Clin Immunol; 2021 Dec; 148(6):1559-1574.e13. PubMed ID: 33872653
[TBL] [Abstract][Full Text] [Related]
37. Structural insights into the assembly of CARMA1 and BCL10.
Li S; Yang X; Shao J; Shen Y
PLoS One; 2012; 7(8):e42775. PubMed ID: 22880103
[TBL] [Abstract][Full Text] [Related]
38. TAK1 lessens the activity of the paracaspase MALT1 during T cell receptor signaling.
Nicolau CA; Gavard J; Bidère N
Cell Immunol; 2020 Jul; 353():104115. PubMed ID: 32388054
[TBL] [Abstract][Full Text] [Related]
39. AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-κB signaling upon T cell activation.
Schimmack G; Eitelhuber AC; Vincendeau M; Demski K; Shinohara H; Kurosaki T; Krappmann D
Cell Commun Signal; 2014 Jul; 12():49. PubMed ID: 25245034
[TBL] [Abstract][Full Text] [Related]
40. Cellular and Mathematical Analyses of LUBAC Involvement in T Cell Receptor-Mediated NF-κB Activation Pathway.
Oikawa D; Hatanaka N; Suzuki T; Tokunaga F
Front Immunol; 2020; 11():601926. PubMed ID: 33329596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
